Welcome to Crene Biotechnology!

+86-576-88205808

Product :

Secukinumab

Secukinumab 1229022-83-6
Size Price Stock Quantity
Get Quotation Now Add to Cart Bulk Inquiry
Shipping and handling fee USD40, Free delivery is qualified when the total value of your order exceeds USD500.If the item is temporarily out of stock. Please email to order@pharm-intermediates.com,we will inform you when we have it in stock.
Chemical Information
Product name:Secukinumab Purity:95% min
CAS NO:1229022-83-6 Solubility:Soluble in DMSO
Molecular Formula:C6584H10134N1754O2042S44 Package:Package according to customer requirements.
Molecular Weight:147.94 kg/mol g/mol Storage:Store at -20℃
Quality control
COA
Remarks

Secukinumab, is a human IgG1κ monoclonal antibody that binds to the protein interleukin (IL)-17A, and is marketed by Novartis for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis. It inhibits a member of the cytokine family, interleukin 17A.

 

 

 

Related Prodcuts: 

Pembrolimumab; Infliximab; Ramucirumab; Ipilimumab; Atezolizumab; Daratumumab; Dulaglutide; Rituximab; Adalimumab; Nivolumab; Denosumab; Cetuximab; Bevacizumab; Aflibercept  

References
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Friendly link:

Copyright Copyright (C) 2018-2024 Taizhou Crene Biotechnology Co.,Ltd.  

Address:Economic Developed Zone of Taizhou Zhejiang China